Peripheral Vascular Stents-Pipeline Review, 2015

Peripheral Vascular Stents-Pipeline Review, 2015


  • Products Id :- GDME0008EPD
  • |
  • Pages: 166
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Peripheral Vascular Stents-Pipeline Review, 2015

GlobalData's Medical Devices sector report, "Peripheral Vascular Stents-Pipeline Review, 2015" provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key peripheral vascular stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Peripheral Vascular Stents products under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Peripheral Vascular Stents under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 8

2 Introduction 9

2.1 Peripheral Vascular Stents Overview 9

3 Products under Development 11

3.1 Peripheral Vascular Stents-Pipeline Products by Stage of Development 11

3.2 Peripheral Vascular Stents-Pipeline Products by Segment 12

3.3 Peripheral Vascular Stents-Pipeline Products by Territory 13

3.4 Peripheral Vascular Stents-Pipeline Products by Regulatory Path 14

3.5 Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date 15

3.6 Peripheral Vascular Stents-Ongoing Clinical Trials 16

4 Peripheral Vascular Stents-Pipeline Products under Development by Companies 17

4.1 Peripheral Vascular Stents Companies-Pipeline Products by Stage of Development 17

4.2 Peripheral Vascular Stents-Pipeline Products by Stage of Development 19

5 Peripheral Vascular Stents Companies and Product Overview 21

5.1 3D Biotek, LLC Company Overview 21

5.1.1 3D Biotek, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 480 Biomedical, Inc. Company Overview 22

5.2.1 480 Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Abbott Vascular Inc. Company Overview 27

5.3.1 Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.4 Andramed GmbH Company Overview 31

5.4.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 31

5.5 Biotronik SE & Co. KG Company Overview 35

5.5.1 Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 35

5.6 Boston Scientific Corporation Company Overview 41

5.6.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 41

5.7 Contego Medical, LLC Company Overview 44

5.7.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 44

5.8 Cook Medical Incorporated Company Overview 45

5.8.1 Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 45

5.9 Cordis Corporation Company Overview 54

5.9.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 54

5.10 CorInnova, Inc. Company Overview 58

5.10.1 CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

5.11 Cytograft Tissue Engineering, Inc. Company Overview 59

5.11.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

5.12 Elixir Medical Corporation Company Overview 60

5.12.1 Elixir Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 60

5.13 HEXACATH Company Overview 61

5.13.1 HEXACATH Pipeline Products & Ongoing Clinical Trials Overview 61

5.14 InspireMD, Inc. Company Overview 63

5.14.1 InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63

5.15 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 67

5.15.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

5.16 MicroVention, Inc. Company Overview 68

5.16.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

5.17 Nipro Corporation Company Overview 69

5.17.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 69

5.18 NSVascular, Inc. Company Overview 71

5.18.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

5.19 Palmaz Scientific, Inc. Company Overview 73

5.19.1 Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73

5.20 Stentys, SA Company Overview 74

5.20.1 Stentys, SA Pipeline Products & Ongoing Clinical Trials Overview 74

5.21 Stron Medical Company Overview 76

5.21.1 Stron Medical Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 Taewoong Medical Co.,Ltd. Company Overview 78

5.22.1 Taewoong Medical Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78

5.23 Tepha, Inc. Company Overview 85

5.23.1 Tepha, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85

5.24 Terumo Corporation Company Overview 86

5.24.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 86

5.25 University of Texas Medical Branch at Galveston Company Overview 90

5.25.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 90

5.26 Veniti, Inc. Company Overview 92

5.26.1 Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92

5.27 Veryan Medical Limited Company Overview 95

5.27.1 Veryan Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 95

5.28 VueKlar Cardiovascular Ltd. Company Overview 98

5.28.1 VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98

5.29 W. L. Gore & Associates, Inc. Company Overview 100

5.29.1 W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100

6 Peripheral Vascular Stents- Recent Developments 101

7 Appendix 163

7.1 Methodology 163

7.2 About GlobalData 165

7.3 Contact Us 165

7.4 Disclaimer 166

1.2 List of Figures

Figure 1: Peripheral Vascular Stents-Pipeline Products by Stage of Development 11

Figure 2: Peripheral Vascular Stents-Pipeline Products by Segment 12

Figure 3: Peripheral Vascular Stents-Pipeline Products by Territory 13

Figure 4: Peripheral Vascular Stents-Pipeline Products by Regulatory Path 14

Figure 5: Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date 15

Figure 6: Peripheral Vascular Stents-Ongoing Clinical Trials 16

1.1 List of Tables

Table 1: Peripheral Vascular Stents-Pipeline Products by Stage of Development 11

Table 2: Peripheral Vascular Stents-Pipeline Products by Segment 12

Table 3: Peripheral Vascular Stents-Pipeline Products by Territory 13

Table 4: Peripheral Vascular Stents-Pipeline Products by Regulatory Path 14

Table 5: Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date 15

Table 6: Peripheral Vascular Stents-Ongoing Clinical Trials 16

Table 7: Peripheral Vascular Stents Companies-Pipeline Products by Stage of Development 17

Table 8: Peripheral Vascular Stents-Pipeline Products by Stage of Development 19

Table 9: 3D Biotek, LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Table 10: Bioresorbable Drug Eluting Peripheral Polymer Stent-Product Status 21

Table 11: Bioresorbable Drug Eluting Peripheral Polymer Stent-Product Description 21

Table 12: 480 Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

Table 13: Stanza Bioresorbable Pediatric Scaffold-Product Status 22

Table 14: Stanza Bioresorbable Pediatric Scaffold-Product Description 22

Table 15: Stanza Bioresorbable Self-Expanding Scaffold-Product Status 23

Table 16: Stanza Bioresorbable Self-Expanding Scaffold-Product Description 23

Table 17: Stanza Drug Eluting Bioresorbable Scaffold-Product Status 24

Table 18: Stanza Drug Eluting Bioresorbable Scaffold-Product Description 24

Table 19: 480 Biomedical, Inc.-Ongoing Clinical Trials Overview 25

Table 20: Stanza Drug Eluting Bioresorbable Scaffold-An Evaluation of the 480 Biomedical STANZA Drug-Eluting Resorbable Scaffold (DRS) System in the Treatment of de Novo SFA Lesions 26

Table 21: Abbott Vascular Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

Table 22: ESPRIT Bioresorbable Vascular Scaffold-Product Status 27

Table 23: ESPRIT Bioresorbable Vascular Scaffold-Product Description 28

Table 24: Next Generation SUPERA Delivery System-Product Status 28

Table 25: Next Generation SUPERA Delivery System-Product Description 28

Table 26: Abbott Vascular Inc.-Ongoing Clinical Trials Overview 29

Table 27: ESPRIT Bioresorbable Vascular Scaffold-A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System for the Treatment of Subjects With Symptomatic Claudication From Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries 30

Table 28: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 31

Table 29: AndraStent U-Flex Peripheral Nitinol Stent System 5F-Product Status 31

Table 30: AndraStent U-Flex Peripheral Nitinol Stent System 5F-Product Description 32

Table 31: AndraStent U-Flex Peripheral Nitinol Stent System 6F-Product Status 32

Table 32: AndraStent U-Flex Peripheral Nitinol Stent System 6F-Product Description 32

Table 33: AndraStent XL-Product Status 33

Table 34: AndraStent XL-Product Description 33

Table 35: AndraStent XXL-Product Status 34

Table 36: AndraStent XXL-Product Description 34

Table 37: Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 35

Table 38: Astron Peripheral Vascular Stent-Product Status 35

Table 39: Astron Peripheral Vascular Stent-Product Description 35

Table 40: Astron Pulsar Self Expanding Peripheral Stent-Product Status 36

Table 41: Astron Pulsar Self Expanding Peripheral Stent-Product Description 36

Table 42: Pulsar-18 Self Expanding Stent-Product Status 37

Table 43: Pulsar-18 Self Expanding Stent-Product Description 37

Table 44: Biotronik SE & Co. KG-Ongoing Clinical Trials Overview 38

Table 45: Astron Pulsar Self Expanding Peripheral Stent-The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents 39

Table 46: Astron Pulsar Self Expanding Peripheral Stent-The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar-18 Stents (BIOFLEX-I Europe) 39

Table 47: Astron Peripheral Vascular Stent-The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents 40

Table 48: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 41

Table 49: Cobalt-Chromium Iliac Balloon Expandable Stent-Product Status 41

Table 50: Cobalt-Chromium Iliac Balloon Expandable Stent-Product Description 42

Table 51: Innova Peripheral Vascular Drug-Eluting Stent System-Product Status 42

Table 52: Innova Peripheral Vascular Drug-Eluting Stent System-Product Description 42

Table 53: INNOVA Self-Expanding Bare-Metal Stent System-Product Status 43

Table 54: INNOVA Self-Expanding Bare-Metal Stent System-Product Description 43

Table 55: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 44

Table 56: VANGUARD-Product Status 44

Table 57: VANGUARD-Product Description 44

Table 58: Cook Medical Incorporated Pipeline Products & Ongoing Clinical Trials Overview 45

Table 59: Evolution Biliary Stent System-Partially Covered-Product Status 45

Table 60: Evolution Biliary Stent System-Partially Covered-Product Description 46

Table 61: Evolution Esophageal Stent System-Fully Covered-Product Status 46

Table 62: Evolution Esophageal Stent System-Fully Covered-Product Description 46

Table 63: ZILVER PTX Drug Eluting Peripheral Stent-Product Status 47

Table 64: ZILVER PTX Drug Eluting Peripheral Stent-Product Description 47

Table 65: Zilver Vena Venous Self-Expanding Stent-Product Status 48

Table 66: Zilver Vena Venous Self-Expanding Stent-Product Description 48

Table 67: Cook Medical Incorporated-Ongoing Clinical Trials Overview 49

Table 68: ZILVER PTX Drug Eluting Peripheral Stent-Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions (BATTLE) 50

Table 69: ZILVER PTX Drug Eluting Peripheral Stent-Evaluation of the Zilver PTX Drug-Eluting Peripheral Stent for Treatment of Lesions of the Above-the-knee Femoropopliteal Artery 50

Table 70: ZILVER PTX Drug Eluting Peripheral Stent-The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions (ZILVERPASS) 50

Table 71: ZILVER PTX Drug Eluting Peripheral Stent-Zilver Paclitaxel(PTX) Thumbwheel Delivery System 51

Table 72: ZILVER PTX Drug Eluting Peripheral Stent-Zilver PTX Drug-Eluting Peripheral Stent Post-Approval Study 51

Table 73: ZILVER PTX Drug Eluting Peripheral Stent-Zilver PTX Post-market Surveillance Study of Paclitaxel-eluting Stents for Treating Femoropopliteal Artery Disease in Japan 51

Table 74: Zilver Vena Venous Self-Expanding Stent-Evaluation of the Zilver Vena Venous Stent 52

Table 75: Zilver Vena Venous Self-Expanding Stent-Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction 52

Table 76: Evolution Esophageal Stent System-Fully Covered-Clinical Investigation to Evaluate Removal of the Evolution Esophageal Stent-Fully Covered 53

Table 77: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 54

Table 78: FlexStent Femoropopliteal Self Expanding Stent System-Product Status 54

Table 79: FlexStent Femoropopliteal Self Expanding Stent System-Product Description 55

Table 80: Cordis Corporation-Ongoing Clinical Trials Overview 56

Table 81: FlexStent Femoropopliteal Self Expanding Stent System-Evaluation of Safety and Efficacy of the FlexStent Femoropopliteal Self-Expanding Stent System Study 57

Table 82: CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58

Table 83: Hybrid Dynamic Stent-Product Status 58

Table 84: Hybrid Dynamic Stent-Product Description 58

Table 85: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

Table 86: LifeJacket Stent Graft-Peripheral-Product Status 59

Table 87: LifeJacket Stent Graft-Peripheral-Product Description 59

Table 88: Elixir Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 60

Table 89: Peripheral Vascular Resorbable Scaffold-Product Status 60

Table 90: Peripheral Vascular Resorbable Scaffold-Product Description 60

Table 91: HEXACATH Pipeline Products & Ongoing Clinical Trials Overview 61

Table 92: HELIOS LD Peripheral Balloon Expandable Bio Active Stent-Product Status 61

Table 93: HELIOS LD Peripheral Balloon Expandable Bio Active Stent-Product Description 62

Table 94: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63

Table 95: CGuard Embolic Protection System-Product Status 63

Table 96: CGuard Embolic Protection System-Product Description 64

Table 97: MGuard Carotid-Product Status 64

Table 98: MGuard Carotid-Product Description 65

Table 99: PVGuard Peripheral-Product Status 65

Table 100: PVGuard Peripheral-Product Description 65

Table 101: RGuard Renal-Product Status 66

Table 102: RGuard Renal-Product Description 66

Table 103: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

Table 104: Peripheral Bare Stent-Product Status 67

Table 105: Peripheral Bare Stent-Product Description 67

Table 106: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

Table 107: CASPER Carotid Stent-Product Status 68

Table 108: CASPER Carotid Stent-Product Description 68

Table 109: Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 69

Table 110: Peripheral Stent-Product Status 69

Table 111: Peripheral Stent-Product Description 70

Table 112: NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

Table 113: Micropatterned TFN Stent-Product Status 71

Table 114: Micropatterned TFN Stent-Product Description 72

Table 115: Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73

Table 116: Micro-Mesh Covered Carotid Stent-Product Status 73

Table 117: Micro-Mesh Covered Carotid Stent-Product Description 73

Table 118: Stentys, SA Pipeline Products & Ongoing Clinical Trials Overview 74

Table 119: STENTYS DES-Critical Limb Ischemia-Product Status 74

Table 120: STENTYS DES-Critical Limb Ischemia-Product Description 75

Table 121: Stron Medical Pipeline Products & Ongoing Clinical Trials Overview 76

Table 122: Biodegradable Biliary Stent-Product Status 76

Table 123: Biodegradable Biliary Stent-Product Description 76

Table 124: Tracheobronchial Stent-Product Status 77

Table 125: Tracheobronchial Stent-Product Description 77

Table 126: Taewoong Medical Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78

Table 127: Niti-S Bumpy Biliary Stent-Product Status 78

Table 128: Niti-S Bumpy Biliary Stent-Product Description 79

Table 129: Niti-S Comvi Biliary Stent-Product Status 79

Table 130: Niti-S Comvi Biliary Stent-Product Description 79

Table 131: Niti-S Giobor Biliary Stent-Product Status 80

Table 132: Niti-S Giobor Biliary Stent-Product Description 80

Table 133: Niti-S Kaffes Biliary Stent-Product Status 80

Table 134: Niti-S Kaffes Biliary Stent-Product Description 81

Table 135: Niti-S LCD Biliary Stent-Product Status 81

Table 136: Niti-S LCD Biliary Stent-Product Description 81

Table 137: Niti-S Nagi Stent-Product Status 82

Table 138: Niti-S Nagi Stent-Product Description 82

Table 139: Niti-S S Biliary Covered Stent-Product Status 83

Table 140: Niti-S S Biliary Covered Stent-Product Description 83

Table 141: Niti-S S Biliary Uncovered Stent-Product Status 84

Table 142: Niti-S S Biliary Uncovered Stent-Product Description 84

Table 143: Tepha, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85

Table 144: TephaFLEX Fully Absorbable Peripheral Stent-Product Status 85

Table 145: TephaFLEX Fully Absorbable Peripheral Stent-Product Description 85

Table 146: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 86

Table 147: MISAGO Self-expanding Stent System-Product Status 86

Table 148: MISAGO Self-expanding Stent System-Product Description 87

Table 149: Terumo Corporation-Ongoing Clinical Trials Overview 88

Table 150: MISAGO Self-expanding Stent System-Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions (BATTLE) 89

Table 151: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 90

Table 152: Intraluminal Stent With Seam-Product Status 90

Table 153: Intraluminal Stent With Seam-Product Description 91

Table 154: Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92

Table 155: VICI Venous Stent-Product Status 92

Table 156: VICI Venous Stent-Product Description 92

Table 157: Veniti, Inc.-Ongoing Clinical Trials Overview 93

Table 158: VICI Venous Stent-VIRTUS-OUS Safety and Efficacy of the Veniti Vici Venous Stent System (Veniti, Inc.) When Used to Treat Clinically Significant Chronic Non-malignant Obstruction of the Iliofemoral Venous Segment 94

Table 159: Veryan Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 95

Table 160: BioMimics 3D Stent-Product Status 95

Table 161: BioMimics 3D Stent-Product Description 95

Table 162: Veryan Medical Limited-Ongoing Clinical Trials Overview 96

Table 163: BioMimics 3D Stent-Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease: MIMICS-2 97

Table 164: VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98

Table 165: MR-Enhancing Balloon Expandable Stent-Product Status 98

Table 166: MR-Enhancing Balloon Expandable Stent-Product Description 98

Table 167: MR-Enhancing Self-Expanding Stent-Product Status 99

Table 168: MR-Enhancing Self-Expanding Stent-Product Description 99

Table 169: W. L. Gore & Associates, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100

Table 170: GORE Carotid Stent-Product Status 100

Table 171: GORE Carotid Stent-Product Description 100

Table 172: Glossary 164

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

3D Biotek, LLC, Bioresorbable Drug Eluting Peripheral Polymer Stent, 480 Biomedical, Inc., Stanza Bioresorbable Pediatric Scaffold, Stanza Bioresorbable Self-Expanding Scaffold, Stanza Drug Eluting Bioresorbable Scaffold, Abbott Vascular Inc., ESPRIT Bioresorbable Vascular Scaffold, Next Generation SUPERA Delivery System, Andramed GmbH, AndraStent U-Flex Peripheral Nitinol Stent System 5F, AndraStent U-Flex Peripheral Nitinol Stent System 6F, AndraStent XL, AndraStent XXL, Biotronik SE & Co. KG, Astron Peripheral Vascular Stent, Astron Pulsar Self Expanding Peripheral Stent, Pulsar-18 Self Expanding Stent, Boston Scientific Corporation, Cobalt-Chromium Iliac Balloon Expandable Stent, Innova Peripheral Vascular Drug-Eluting Stent System, INNOVA Self-Expanding Bare-Metal Stent System, Contego Medical, LLC, VANGUARD, Cook Medical Incorporated, Evolution Biliary Stent System-Partially Covered, Evolution Esophageal Stent System-Fully Covered, ZILVER PTX Drug Eluting Peripheral Stent, Zilver Vena Venous Self-Expanding Stent, Cordis Corporation, FlexStent Femoropopliteal Self Expanding Stent System, CorInnova, Inc., Hybrid Dynamic Stent, Cytograft Tissue Engineering, Inc., LifeJacket Stent Graft - Peripheral, Elixir Medical Corporation, Peripheral Vascular Resorbable Scaffold, HEXACATH, HELIOS LD Peripheral Balloon Expandable Bio Active Stent, InspireMD, Inc., CGuard Embolic Protection System, MGuard Carotid, PVGuard Peripheral, RGuard Renal, Lifetech Scientific (Shenzhen) Co., Ltd., Peripheral Bare Stent, MicroVention, Inc., CASPER Carotid Stent, NSVascular, Inc., Micropatterned TFN Stent, Palmaz Scientific, Inc., Micro-Mesh Covered Carotid Stent, Silk Road Medical, Inc., ENROUTE Transcarotid Stent System, Stentys, SA, STENTYS DES - Critical Limb Ischemia, Stron Medical, Biodegradable Biliary Stent, Tracheobronchial Stent, Taewoong Medical Co.,Ltd., Niti-S Bumpy Biliary Stent, Niti-S Comvi Biliary Stent, Niti-S Giobor Biliary Stent, Niti-S Kaffes Biliary Stent, Niti-S LCD Biliary Stent, Niti-S Nagi Stent, Niti-S S Biliary Covered Stent, Niti-S S Biliary Uncovered Stent, Tepha, Inc., TephaFLEX Fully Absorbable Peripheral Stent, Terumo Corporation, MISAGO Self-expanding Stent System, University of Texas Medical Branch at Galveston, Intraluminal Stent With Seam, Veniti, Inc., VICI Venous Stent, Veryan Medical Limited, BioMimics 3D Stent, VueKlar Cardiovascular Ltd., MR-Enhancing Balloon Expandable Stent, MR-Enhancing Self-Expanding Stent, W. L. Gore & Associates, Inc., GORE Carotid Stent

select a license

Single User License
USD 4000 INR 258280
Site License
USD 8000 INR 516560
Corporate User License
USD 12000 INR 774840

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com